Mark Stahl
Neurocrine Biosciences (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neurological diseases and metabolism, Developmental Biology and Gene Regulation, Autophagy in Disease and Therapy
Most-Cited Works
- → Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease(2012)205 cited
- → Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling(2008)174 cited
- → A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo(2012)160 cited
- → Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos(2016)79 cited
- → Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity(2014)77 cited
- → Canonical Notch Signaling Is Dispensable for Early Cell Fate Specifications in Mammals(2005)57 cited
- → Notch1-Induced Transformation of RKE-1 Cells Requires Up-regulation of Cyclin D1(2006)52 cited
- → Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-d-Glucose(2005)51 cited
- → O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors(2008)37 cited
- The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.(2003)